Quantum-Si Incorporated
QSIQuantum-Si is a life sciences company that has developed a proprietary, universal single-molecule detection platform for next-generation protein sequencing (NGPS).
Table of contents
Earnings
Next report
Aug 13, 2026 (In 2 weeks)Competitors
By market cap
By revenue growth
Profile
Quantum-Si is a life sciences company that has developed a proprietary, universal single-molecule detection platform for next-generation protein sequencing (NGPS). The company's technology democratizes proteomics research by providing a massively parallel, automated, and cost-effective alternative to legacy mass spectrometry and affinity-based methods. Their platform enables researchers to gain deep biological insights into the proteome at single-molecule resolution to study disease pathways, biomarkers, and drug discovery.
Quantum-Si is a pioneer in the next-generation protein sequencing (NGPS) market, offering the first successfully commercialized NGPS product with a focus on low capital cost and automated analysis.
Questions, answered.
- What is Quantum-Si Incorporated's market cap?
- Quantum-Si Incorporated (QSI) has a market capitalization of $170.6M and trades on NASDAQ.
- Who are Quantum-Si Incorporated's competitors?
- Quantum-Si Incorporated's key competitors include Nautilus Biotechnology, Thermo Fisher Scientific, Seer, Inc. Class A Common Stock, and others. These companies compete in similar markets and product categories.
- What subsidiaries does Quantum-Si Incorporated have?
- Quantum-Si Incorporated's subsidiaries include Q-SI Operations Inc..
- Where is Quantum-Si Incorporated headquartered?
- Quantum-Si Incorporated is headquartered in United States of America and employs approximately 165 people. It has been publicly traded since 2021.